T2	Participants 463 495	Ten centers in the United States
T3	Participants 506 656	Adult (age >or=18 years) critically ill patients with hemoglobin <or=12 g/dL, expected hospitalization of >or=7 days, with no ongoing acute blood loss
T1	Participants 1146 1351	Of the 60 patients who were enrolled (60% men, mean age 53 years, mean Acute Physiology and Chronic Health Evaluation II score, 19.5), 30 were evaluable for both pharmacokinetics and pharmacodynamics (50%)
